Category Archives: OTC Switches

Plan B Available OTC

Plan B will become available this week without a prescription, New York Newsday reports.  It is about time. There are also reports that criticism has been voiced over the fact that the manufacturer has achieved exclusivity for a three year … Continue reading

Posted in OTC Switches | Comments Off

The Cold War

Recently Congressman Henry Waxman (D-CA) has been involved in correspondence with Acting Commissioner Andrew C. von Eschenbach.  He wrote on August 23, September 22 and now again on October 23.  It seems to be a monthly thing. His concern is … Continue reading

Posted in FDA Policy, OTC Switches | Comments Off

A Study of Statins

There is perhaps no better candidate in the pipeline for an RX to OTC switch than for statins.  Statins lower cholesterol dramatically and therefore one can intuit – they would lower the rate of heart disease in this country if … Continue reading

Posted in OTC Switches | Comments Off

FDA, the Commissioner and Plan B

Apparently now it is being reported by the Minneapolis Star Tribune and Associated Press that Dr. Lester Crawford is stating that there was no attempt to disallow Plan B’s switch from RX to OTC, but rather that he delayed the … Continue reading

Posted in FDA Policy, OTC Switches | 1 Comment

Good Time to Move on Plan B

Last week, former Acting Commissioner and former Commissioner Lester B. Crawford admitted in a deposition that he acted to pre-empt FDA staff from approving the OTC switch of Plan B, according to a report in the Baltimore Sun.  What he … Continue reading

Posted in FDA Policy, OTC Switches | Comments Off